Project Grant R35GM158109

Award Date 7/1/25
Completion Date 4/30/30
Dollars Obligated $433K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $284,184 to Duke University to investigate the role of the CuZnSOD1 protein in sensing copper-deficient conditions in the fungus Candida albicans. The research aims to further elucidate the mechanisms by which C. albicans, a common human pathogen, adapts its copper homeostasis pathways in response to copper-deficient...
This federal Project Grant award of $364,324 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research on the regulation of copper metabolism by hydrogen sulfide (H2S) signaling. The key objectives are to: Characterize how sulfide exposure impacts copper levels, distribution, and the expression of copper-binding proteins across various cell lines and in intestinal tissue from mice. This includes...
This federal Project Grant award, totaling $349,074, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program. The grant supports research to develop and apply 13C-enhanced nuclear magnetic resonance (NMR) spectroscopy methods to study the structure and function of lysine acetylation, a ubiquitous protein post-translational modification. The key products and services to be delivered include: 1)...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to investigate the effects of polyamines on chromatin function and their impact on cell fate and chromatin homeostasis. The 5-year, $411,250 award to The Trustees of Columbia University in the City of New York will enable the principal investigator to explore how changes in intracellular and extracellular polyamines...
This $368,110 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to study the structures and properties of key enzymatic intermediates involved in oxygenase chemistry. The research aims to develop peptide-based synthetic models that can mimic the active sites and reactivity of non-heme iron and copper oxygenases, which are critical for metabolism, natural product...
This Project Grant award, valued at $398,750.00 and issued by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) federal grant program, aims to enable molecular approaches for copper-based radiopharmaceuticals. The research project will focus on advancing the design of bifunctional chelators (BFCs) to achieve exceptional in vivo kinetic stability of copper-based radiopharmaceuticals, which have shown promise for imaging...
This Project Grant award of $466,125.00 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, supports research to identify and characterize key metabolic control mechanisms. The research aims to: Study the physiological importance of an evolutionarily conserved mechanism by which cells sense pyrimidine levels, using genetically engineered cell and mouse models. This will delineate the role of allosteric...
This $391,250 five-year Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to uncover the mechanistic basis for how chromatin modifications recruit and activate the gene silencing enzymes Polycomb Repressive Complex 1 (PRC1), Polycomb Repressive Complex 2 (PRC2), and DNA Methyltransferase 1 (DNMT1). The awardee, The Regents of the University of Colorado (CU), will utilize an...
The National Institute of General Medical Sciences (NIGMS) awarded a $147,656 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of California, Davis. The grant will fund advanced spectroscopic studies of enzymatic intermediates containing iron-sulfur clusters. Specific objectives include: Characterizing the paramagnetic intermediates of the biotin synthase enzyme BioB, which utilizes an uncommon [4Fe-5S] auxiliary cluster, using electron...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,487 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Illinois to support research on "Uncovering Novel Heme Chemistry in Microbial Systems." The project aims to expand understanding of how diverse bacterial diheme proteins stabilize high-valent bis-FeIV states and leverage these intermediates for site-specific substrate oxidation. Key focus areas include...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $433,125 to the University of California, Los Angeles (UCLA) to expand the understanding of histone H3 as a copper reductase enzyme.

The key objectives of this 5-year project are to: 1) develop a detailed understanding of the enzymatic activity of histone H3 within nucleosomes, 2) examine how this activity integrates with cellular metabolism and copper homeostasis, and 3) investigate potential connections between copper regulation, mitochondrial function, and the nucleus. The research aims to provide a new metabolic context for understanding the eukaryotic nucleosome, with potential implications for eukaryogenesis and human diseases like Friedreich's ataxia.

Generated 7/15/25, 10:06 AM